Logo

RYAM

Rayonier Advanced Materials Inc.

RYAM

Rayonier Advanced Materials Inc. NYSE
$6.53 0.15% (+0.01)

Market Cap $437.55 M
52w High $8.90
52w Low $3.35
Dividend Yield 0%
P/E -1.04
Volume 326.82K
Outstanding Shares 67.01M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $353M $24.262M $-4M -1.133% $-0.06 $65.147M
Q2-2025 $340.048M $24.98M $-363.197M -106.808% $-5.44 $28.721M
Q1-2025 $355.967M $39.147M $-31.97M -8.981% $-0.49 $17.682M
Q4-2024 $422.504M $25.934M $-16.219M -3.839% $-0.25 $39.58M
Q3-2024 $401.103M $60.369M $-32.598M -8.127% $-0.49 $19.004M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $77.03M $1.796B $1.445B $338.214M
Q2-2025 $70.679M $1.755B $1.4B $342.318M
Q1-2025 $129.86M $2.118B $1.418B $688.084M
Q4-2024 $125.222M $2.13B $1.405B $713.885M
Q3-2024 $136.091M $2.159B $1.427B $732.712M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-4.454M $-17.787M $-22.193M $46.523M $6.351M $-41.48M
Q2-2025 $-363.179M $-30.178M $-37.47M $1.631M $-59.181M $-67.648M
Q1-2025 $-31.952M $39.616M $-37.51M $-718K $4.638M $2.106M
Q4-2024 $-15.929M $54.92M $-28.279M $-32.5M $-10.869M $26.641M
Q3-2024 $-35.815M $49.832M $-21.645M $-8.871M $21.945M $28.187M

Revenue by Products

Product Q3-2024Q1-2025Q2-2025Q3-2025
Biomaterials
Biomaterials
$0 $10.00M $10.00M $10.00M
Cellulose Specialties
Cellulose Specialties
$0 $200.00M $210.00M $200.00M
Paperboard
Paperboard
$0 $50.00M $50.00M $40.00M
Commodity Products
Commodity Products
$0 $80.00M $0 $0
High Purity Cellulose Segment
High Purity Cellulose Segment
$320.00M $0 $0 $0
Highyield Pulp Segment
Highyield Pulp Segment
$30.00M $0 $0 $0
Paperboard Segment
Paperboard Segment
$50.00M $0 $0 $0

Five-Year Company Overview

Income Statement

Income Statement Rayonier Advanced Materials shows a business with fairly steady sales but thin profitability. Over the last several years, revenue has moved in a narrow range rather than trending clearly up or down. Gross profit has stayed positive but relatively low, which limits earnings power. Operating results have swung between small profits and small losses, and net income has been negative in most recent years, including the latest one. That said, operating performance did improve recently compared with the prior year, with better operating profit and stronger cash-style earnings, even though bottom-line losses remain. Overall, the income statement reflects a company in a tough, cyclical industry working to improve margins but not yet consistently profitable.


Balance Sheet

Balance Sheet The balance sheet shows a moderate-sized asset base that has gradually edged down, suggesting discipline on investment and some asset rationalization. Debt is still meaningful but has been slowly reduced over time, which is a positive sign for long-term financial health. Shareholders’ equity has been fairly stable, indicating that cumulative losses have not yet severely eroded the capital base. Cash balances are modest, though noticeably higher in the most recent year than the one before, which provides a bit more flexibility. In short, the company remains leveraged but is moving in the right direction, with incremental de-risking rather than dramatic change.


Cash Flow

Cash Flow Cash generation is a relative strength compared with accounting earnings. The business has repeatedly produced positive cash flow from operations, even in years when reported profits were negative. Investment spending has been consistently significant, reflecting the capital-intensive nature of pulp and advanced materials, but the company has generally managed to keep free cash flow around breakeven to modestly positive, except for one notably weaker year. The most recent year shows clearly better free cash flow than the prior one, suggesting improved operating efficiency and tighter capital spending control. This cash flow profile helps support ongoing debt reduction and strategic investment despite weak net income.


Competitive Edge

Competitive Edge RYAM operates in a specialized corner of the chemicals and forest products world, focused on high-purity cellulose rather than commodity pulp. Its long history, technical expertise, and large-scale plants give it a meaningful edge in this niche. Customers rely on highly tailored products that are difficult and time-consuming to requalify, which tends to create sticky relationships and high switching costs. The company’s focus on renewable, wood-based inputs also aligns well with rising sustainability demands, providing a differentiation angle versus petrochemical alternatives. However, it still faces typical pressures of a basic materials business: exposure to economic cycles, input cost volatility, and competition from other advanced cellulose and synthetic materials producers. Its moat is meaningful but not immune to industry downturns.


Innovation and R&D

Innovation and R&D Innovation is a central part of RYAM’s strategy. The company runs dedicated research centers and has built deep know-how in cellulose chemistry, allowing it to co-develop highly customized products with customers. Beyond its core cellulose specialties, RYAM is pushing into newer bio-based areas: prebiotic ingredients, bio-based chemicals like tall oil derivatives, second-generation bioethanol, and potentially sustainable aviation fuel through partnerships. These initiatives aim to move the portfolio toward higher-value, lower-carbon applications. The opportunity is significant, but many of these projects are still in early or scaling phases, with technology, commercialization, and policy risks. Success will depend on turning this R&D pipeline into reliable, higher-margin revenue while managing capital intensity and execution risk.


Summary

Overall, RYAM looks like a niche materials company in transition. Its traditional high-purity cellulose business provides a technical and customer relationship backbone, but profits have been inconsistent and often negative. The company has been gradually strengthening its financial footing: trimming debt, maintaining equity, and improving free cash flow even as accounting earnings lag. At the same time, it is investing in a shift toward bio-based, higher-value products and new markets such as biofuels, bio-based polymers, and specialty ingredients. The long-term story hinges on whether this innovation strategy can lift margins and reduce cyclicality faster than industry headwinds and balance sheet constraints weigh on results. Uncertainty remains high, but the direction of travel is toward a leaner balance sheet and a more advanced, sustainability-focused product mix.